BALB/c Nude

1. SMAD4 Palmitoylation Drives a Metabolic-Transcriptional Circuit to Promote Tumorigenesis and Confers Radiosensitivity in Pancreatic Cancer
发表年份：2026 来源杂志：Advanced Science

2. Targeting the FOSL1/IKKα positive feedback loop attenuates glioblastoma malignancy via suppression of NF-κB signaling
发表年份：2026 来源杂志：Theranostics

3. Loss of TFAM Accelerates Pentose Phosphate Pathway by Unleashing G6PD Oligomerization to Drive Hepatocarcinogenesis
发表年份：2026 来源杂志：CANCER LETTERS

4. Melanoma exosomal miR-708-5p promotes macrophage M2 polarization and cancer metastasis
发表年份：2026 来源杂志：Cell Death & Disease

5. GSH-Activated Cu-TCPP(Zn)/Ti3C2Tx Nanozymes for Fluorescence Imaging-Guided Synergistic Photodynamic/Chemodynamic Therapy of Oral Squamous Cell Carcinoma
发表年份：2026 来源杂志：ACS Applied Materials & Interfaces

6. Modulating tumor-associated macrophages through APP-CD74 blockade with IL4R-exosomes synergizes with PD-1 inhibition in gastric cancer
发表年份：2026 来源杂志：npj Precision Oncology

7. ADCY7 dictates N-cadherin stability to inhibit HCC metastasis
发表年份：2026 来源杂志：JHEP Reports

8. MD2 suppresses anaplastic thyroid Cancer progression by reprogramming macrophages via USP15-mediated FHL1 Deubiquitination
发表年份：2026 来源杂志：INTERNATIONAL IMMUNOPHARMACOLOGY

9. KCTD15 Enhances Stem Cell‐Like Properties and Promotes Triple‐Negative Breast Cancer Progression Through KLF4/β‐Catenin Signaling
发表年份：2026 来源杂志：FASEB JOURNAL

10. FOXA2/ALDOB axis modulation of fatty acid beta-oxidation influences irinotecan resistance in colorectal cancer
发表年份：2026 来源杂志：BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH

11. Calycosin exerts anti-glioblastoma effects by inhibiting GPX-4 to promote oxidative stress
发表年份：2026 来源杂志：BRAIN RESEARCH BULLETIN

12. Loss of GPR133 Promotes Enzalutamide Resistance in Prostate Cancer by Upregulating HSD3B1 and Intratumoral Androgen Synthesis
发表年份：2026 来源杂志：PROSTATE

13. Multi-omics analysis identifies BUB1B as a cell cycle–related driver of bladder cancer progression
发表年份：2026 来源杂志：World Journal of Surgical Oncology

14. CEACAM6 silencing suppresses tumour growth and sensitises cholangiocarcinoma to cisplatin
发表年份：2026 来源杂志：Clinical and Translational Discovery

15. RNA target-independent non-canonical activation (RINCA) of Cas13 trans-nuclease activity
发表年份：2025 来源杂志：Science Bulletin

16. Targeting Hyperglycemic Bone Pre-Metastatic Niche for Breast Cancer Bone Metastasis Therapy
发表年份：2025 来源杂志：Advanced Science

17. Malignant Hepatoblast-Like Cells Sustain Stemness via IGF2-Dependent Cholesterol Accumulation in Hepatoblastoma
发表年份：2025 来源杂志：Advanced Science

18. A Self-Assembling LYTAC Mediates CTGF Degradation and Remodels Inflammatory Tumor Microenvironment for Triple-Negative Breast Cancer Therapy
发表年份：2025 来源杂志：Advanced Science

19. NPR1 Promotes Lipid Droplet Lipolysis to Enhance Mitochondrial Oxidative Phosphorylation and Fuel Gastric Cancer Metastasis
发表年份：2025 来源杂志：Advanced Science

20. FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance ʟ-asparagine production
发表年份：2025 来源杂志：Science Advances

21. Targeting the ac4C ‘Writer’ NAT10 enhances pancreatic cancer immunotherapy via dual modulation of CD8+ T cells and tumor cells
发表年份：2025 来源杂志：Cell Death & Disease

22. Sino-C, a novel sinomenine derivative, induces cell death by disrupting cholesterol homeostasis in colorectal cancer cells
发表年份：2025 来源杂志：ACTA PHARMACOLOGICA SINICA

23. Unraveling the secrets of UBE2S in endometrial cancer: Potential targets for diagnosis, prognostic assessment, and ferroptosis therapy
发表年份：2025 来源杂志：CELLULAR SIGNALLING

24. The lysosomal cysteine protease cathepsin L promotes stemness and multidrug resistance of non-small cell lung cancer by targeting HGF activator
发表年份：2025 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

25. APOBEC3B-driven mutations negatively regulated by P53 promote tumor progression and immunosuppressive microenvironment in prostate cancer
发表年份：2025 来源杂志：MOLECULAR AND CELLULAR BIOCHEMISTRY

26. BRAP Promotes the Tumorigenesis of Hepatocellular Carcinoma by Corrupting Cancer Cell Cycle Regulation and Enhancing Immune Evasion
发表年份：2025 来源杂志：Journal of Hepatocellular Carcinoma

27. VDAC1 as prognostic marker and therapeutic target in lung adenocarcinoma: a study integrating bioinformatics and experimental validation
发表年份：2025 来源杂志：Discover Oncology

28. Acevaltrate as a novel ferroptosis inducer with dual targets of PCBP1/2 and GPX4 in colorectal cancer
发表年份：2025 来源杂志：Signal Transduction and Targeted Therapy

29. BCAA-producing Clostridium symbiosum promotes colorectal tumorigenesis through the modulation of host cholesterol metabolism
发表年份：2024 来源杂志：Cell Host & Microbe

30. The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis
发表年份：2024 来源杂志：Nature Microbiology

31. Acetate utilization promotes hormone therapy resistance in prostate cancer through neuroendocrine differentiation
发表年份：2024 来源杂志：DRUG RESISTANCE UPDATES

32. Effect of Bioactive Black Phosphorus Nanomaterials on Cancer-Associated Fibroblast Heterogeneity in Pancreatic Cancer
发表年份：2024 来源杂志：ACS Nano

33. Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma
发表年份：2024 来源杂志：Nature Communications

34. Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism
发表年份：2024 来源杂志：Advanced Science

35. Aspirin-Mediated Acetylation of SIRT1 Maintains Intestinal Immune Homeostasis
发表年份：2024 来源杂志：Advanced Science

36. A STT3A-dependent PD-L1 glycosylation modification mediated by GMPS drives tumor immune evasion in hepatocellular carcinoma
发表年份：2024 来源杂志：CELL DEATH AND DIFFERENTIATION

37. Cuproptosis and Serine Metabolism Blockade Triggered by Copper-Based Prussian Blue Nanomedicine for Enhanced Tumor Therapy
发表年份：2024 来源杂志：Small

38. LncRNA SNHG1 facilitates colorectal cancer cells metastasis by recruiting HNRNPD protein to stabilize SERPINA3 mRNA
发表年份：2024 来源杂志：CANCER LETTERS

39. The interaction between UBR7 and PRMT5 drives PDAC resistance to gemcitabine by regulating glycolysis and immune microenvironment
发表年份：2024 来源杂志：Cell Death & Disease

40. SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1
发表年份：2024 来源杂志：Cell Reports

41. Effect of the mRNA decapping enzyme scavenger (DCPS) inhibitor RG3039 on glioblastoma
发表年份：2024 来源杂志：Journal of Translational Medicine

42. Quercetin Attenuates Cancer-Associated Fibroblast Activation via Tumor-Stromal Interactions and Demonstrates Its Clinical Value in Pancreatic Cancer
发表年份：2024 来源杂志：JOURNAL OF FOOD BIOCHEMISTRY

43. Exosome-derived circCCAR1 promotes CD8 + T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma
发表年份：2023 来源杂志：Molecular Cancer

44. Targeted therapy of central nervous system acute lymphoblastic leukemia with an integrin α6-targeted self-assembling proapoptotic nanopeptide
发表年份：2023 来源杂志：Engineering

45. Epitranscriptic regulation of HRAS by N6-methyladenosine drives tumor progression
发表年份：2023 来源杂志：PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

46. Small extracellular vesicle-mediated miR-320e transmission promotes osteogenesis in OPLL by targeting TAK1
发表年份：2022 来源杂志：Nature Communications

47. Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer
发表年份：2022 来源杂志：JCI Insight

48. Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma
发表年份：2022 来源杂志：Nanomaterials

49. Long non-coding RNA TDRG1 aggravates colorectal cancer stemness by binding with miR-873-5p to upregulate PRKAR2
发表年份：2022 来源杂志：ENVIRONMENTAL TOXICOLOGY

50. CtBP proteins transactivate matrix metalloproteinases and proinflammatory cytokines to mediate the pathogenesis of abdominal aortic aneurysm
发表年份：2022 来源杂志：EXPERIMENTAL CELL RESEARCH

51. Sanguinarine Represses the Growth and Metastasis of Non-small Cell Lung Cancer by Facilitating Ferroptosis
发表年份：2022 来源杂志：CURRENT PHARMACEUTICAL DESIGN

52. Tripartite Motif Containing 26 is a Positive Predictor for Endometrial Carcinoma Patients and Regulates Cell Survival in Endometrial Carcinoma
发表年份：2022 来源杂志：HORMONE AND METABOLIC RESEARCH

53. RNA-binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA
发表年份：2021 来源杂志：Clinical and Translational Medicine

54. Tumour-Targeted and Redox-Responsive Mesoporous Silica Nanoparticles for Controlled Release of Doxorubicin and an siRNA Against Metastatic Breast Cancer
发表年份：2021 来源杂志：International Journal of Nanomedicine

55. Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis
发表年份：2021 来源杂志：Frontiers in Oncology

56. Downregulated F-Box/LRR-Repeat Protein 7 Facilitates Pancreatic Cancer Metastasis by Regulating Snail1 for Proteasomal Degradation
发表年份：2021 来源杂志：Frontiers in Genetics

57. RNF168 suppresses the cancer stem cell-like traits of nonsmall cell lung cancer cells by mediating RhoC ubiquitination
发表年份：2021 来源杂志：ENVIRONMENTAL TOXICOLOGY

58. Fat1 suppresses the tumor-initiating ability of nonsmall cell lung cancer cells by promoting Yes-associated protein 1 nuclear-cytoplasmic translocation
发表年份：2021 来源杂志：ENVIRONMENTAL TOXICOLOGY

59. Long non‑coding RNA LINC01224 promotes cell proliferation and inhibits apoptosis by regulating AKT3 expression via targeting miR‑485‑5p in endometrial carcinoma
发表年份：2021 来源杂志：ONCOLOGY REPORTS

60. Activation of Gonadotropin-releasing Hormone Receptor Impedes the Immunosuppressive Activity of Decidual Regulatory T Cells via Deactivating the Mechanistic Target of Rapamycin Signaling
发表年份：2021 来源杂志：IMMUNOLOGICAL INVESTIGATIONS

61. Propofol modulates the proliferation, invasion and migration of bladder cancer cells through the miR‑145‑5p/TOP2A axis
发表年份：2021 来源杂志：Molecular Medicine Reports

62. Upregulated osteoprotegerin expression promotes lung cancer cell invasion by increasing miR‑20a expression
发表年份：2021 来源杂志：Experimental and Therapeutic Medicine

63. The p53-inducible CLDN7 regulates colorectal tumorigenesis and has prognostic significance
发表年份：2020 来源杂志：NEOPLASIA

64. GKN2 promotes oxidative stress-induced gastric cancer cell apoptosis via the Hsc70 pathway
发表年份：2019 来源杂志：JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

65. Design, synthesis and biological evaluation of the thioether-containing lenalidomide analogs with anti-proliferative activities
发表年份：2019 来源杂志：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

66. Anisomycin inhibits angiogenesis in ovarian cancer by attenuating the molecular sponge effect of the lncRNA‑Meg3/miR‑421/PDGFRA axis
发表年份：2019 来源杂志：INTERNATIONAL JOURNAL OF ONCOLOGY

67. The miRNA-149-5p/MyD88 axis is responsible for ursolic acid-mediated attenuation of the stemness and chemoresistance of non-small cell lung cancer cells
发表年份：2019 来源杂志：ENVIRONMENTAL TOXICOLOGY

68. Elevated MIR100HG promotes colorectal cancer metastasis and is associated with poor prognosis
发表年份：2019 来源杂志：Oncology Letters

69. miR-221/222 activate the Wnt/β-catenin signaling to promote triple-negative breast cancer
发表年份：2018 来源杂志：Journal of Molecular Cell Biology

70. Covalent docking modelling-based discovery of tripeptidyl epoxyketone proteasome inhibitors composed of aliphatic-heterocycles
发表年份：2018 来源杂志：EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

71. Targeting endogenous DLK1 exerts antitumor effect on hepatocellular carcinoma through initiating cell differentiation
发表年份：2016 来源杂志：Oncotarget

72. Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia
发表年份：2016 来源杂志：Stem Cells Translational Medicine

73. Disruption and inactivation of the PP2A complex promotes the proliferation and angiogenesis of hemangioma endothelial cells through activating AKT and ERK
发表年份：2015 来源杂志：Oncotarget